Lonza-Capsugel-Header

Lonza-Capsugel-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Chugai Pharmaceutical

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

SupplySide West 2021

Participation Not Confirmed

Update your Virtual Booth

Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnershi...

Lead Product(s): Engineered Antibodies

Therapeutic Area: Immunology Product Name: Undisclosed

Highest Development Status: Undisclosed Product Type: Large molecule

Partner/Sponsor/Collaborator: Argenx BVBA

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership October 06, 2020

Details:

Argenx and Chugai have entered into a research license and option agreement under which argenx may